UBS Downgrades InterMune To Neutral
Analysts at UBS downgraded InterMune (NASDAQ: ITMN) from Buy to Neutral.
The price target for InterMune has been raised from $52.00 to $74.00.
InterMune shares have jumped 403.30% over the past 52 weeks, while the S&P 500 index has gained 22.33% in the same period.
InterMune shares rose 0.01% to $73.18 at 10:40 a.m. ET.
Latest Ratings for ITMN
|Aug 2014||Cowen & Company||Initiates Coverage on||Market Perform|
|Aug 2014||JMP Securities||Downgrades||Market Outperform||Market Perform|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.